# Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

> **NCT01879163** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 30 (actual)

## Conditions studied

- Tuberculosis (TB)

## Interventions

- **BIOLOGICAL:** MVA85A-IMX313
- **BIOLOGICAL:** MVA85A

## Key facts

- **NCT ID:** NCT01879163
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01879163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01879163, "Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01879163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*